Neonc Technologies (NTHI) Expected to Announce Earnings on Friday

Neonc Technologies (NASDAQ:NTHI) will likely be posting its results before the market opens on Friday, February 20th. Analysts expect Neonc Technologies to post earnings of ($0.37) per share for the quarter.

Neonc Technologies Stock Down 3.0%

NASDAQ NTHI opened at $8.98 on Thursday. The stock has a 50-day moving average of $9.09 and a 200 day moving average of $8.87. Neonc Technologies has a twelve month low of $3.20 and a twelve month high of $25.00.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on NTHI shares. Zacks Research raised Neonc Technologies to a “hold” rating in a research note on Wednesday, January 14th. Weiss Ratings restated a “sell (e+)” rating on shares of Neonc Technologies in a research report on Monday, December 29th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Reduce”.

Insider Activity at Neonc Technologies

In other Neonc Technologies news, President Amir F. Heshmatpour bought 6,000 shares of the stock in a transaction on Monday, November 24th. The shares were bought at an average price of $6.51 per share, with a total value of $39,060.00. Following the purchase, the president directly owned 2,992,000 shares in the company, valued at $19,477,920. This trade represents a 0.20% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Hedge Funds Weigh In On Neonc Technologies

Hedge funds and other institutional investors have recently modified their holdings of the business. Bank of America Corp DE purchased a new stake in Neonc Technologies during the 2nd quarter valued at about $801,000. Vanguard Group Inc. purchased a new stake in shares of Neonc Technologies in the third quarter valued at approximately $1,279,000. 683 Capital Management LLC acquired a new stake in shares of Neonc Technologies in the fourth quarter valued at approximately $442,000. Royal Bank of Canada purchased a new position in Neonc Technologies during the first quarter worth approximately $247,000. Finally, OMERS ADMINISTRATION Corp purchased a new position in Neonc Technologies during the fourth quarter worth approximately $126,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.